The Asia Pacific Sexually Transmitted Diseases (STD) Testing Market would witness market growth of 4.5% CAGR during the forecast period (2021-2027).
Some STDs like chlamydial and gonococcal infections in women need etiological identification of STDs that are expensive and advanced laboratory procedures. However, such laboratory tests are not accessible in the developed and developing nations for the patient's assessment, and those that are available are not helpful in determining rapid treatment recommendations. The lack of simple & quick diagnostics for the detection of most STDs, the high cost of existing STD laboratory testing, and the lack of requisite laboratory infrastructure are creating lucrative opportunities for the key market players.
In India, the government has recognized Sexually transmitted diseases (RTIs/STIs) and other reproductive tract infections (RTIs/STIs) as a public health issue, particularly because of their link to HIV infection. RTI/STI prevention, control, and management is a well-known technique for reducing reproductive morbidity among the sexually active population while also regulating the spread of HIV/AIDS in the country. In addition, National AIDS Control Programme run by the Government of India has created more awareness among population along with increasing STD testing in rural areas. Additionally, the introduction of various advanced and effective testing methods in this region would fuel the regional market growth.
The China market dominated the Asia Pacific Sexually Transmitted Diseases (STD) Testing Market by Country 2020, and would continue to be a dominant market till 2027; thereby, achieving a market value of $13.00 billion by 2027. The Japan market is poised to grow a CAGR of 3.9% during (2021 - 2027). Additionally, The India market would experience a CAGR of 5.1% during (2021 - 2027).
Based on Disease Type, the market is segmented into Chlamydia, Herpes simplex, Gonorrhea, Syphilis, Human papillomavirus (HPV), and Other Disease. Based on the Location of Testing, the market is segmented into Laboratory Testing and Point of care (POC) Testing. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
Free Valuable Insights: The Worldwide Sexually Transmitted Diseases (STD) Testing Market is Projected to reach USD 120 Billion by 2027, at a CAGR of 4.5%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include BioMérieux S.A., Abbott Laboratories, Becton, Dickinson and Company, Hologic, Inc., Thermo Fisher Scientific, Inc., F. Hoffmann-La Roche Ltd., DiaSorin Molecular LLC, Danaher Corporation, Bio-Rad Laboratories, Inc., and OraSure Technologies, Inc.
By Disease Type
By Location of Testing
By Country
Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
Unique Offerings 